FIELD: medicine, phthisiology, pharmacy. SUBSTANCE: invention relates to preparations for topical application in treatment of pulmonary tuberculosis and suppurative-inflammatory diseases. Preparation represents rifampicin in liposomal form and comprises rifampicin, phospholipids, ascorbic acid, α- tocopherol and isotonic solution taken in the definite ratios. Preparation comprises mixture containing phosphatidylcholine, cholesterol or mixture of other phospholipids of animal and/or vegetable origin as phospholipids taken in any combination and ratio. EFFECT: enhanced stability of preparation. 2 cl, 3 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREPARING RIFAMPICIN LIPOSOMAL FORM | 2002 |
|
RU2223764C1 |
| ANTIOXIDANT LIPOSOMAL COMPOSITION FIR INHALATION IN LUNG AND UPPER RESPIRATORY TRACT DISEASES | 2006 |
|
RU2315593C1 |
| LIPOSOMAL AGENT BASED ON UBIQUINOL AND PREPARATION METHOD THEREOF | 2015 |
|
RU2605616C1 |
| METHOD OF PRODUCING LIPOSOMAL FORM OF ISONIASIDE | 2009 |
|
RU2429841C1 |
| METHOD OF OBTAINING CAPSULATED FORM OF ANTITUBERCULOSIS MEDICATIONS OF RIFAMPICIN SERIES | 2009 |
|
RU2420287C1 |
| LIPOSOMAL PERORAL ANTIVIRAL TREATMENT-AND-PROPHYLACTIC AGENT ON BASIS OF HUMAN INTERFERON ALPHA | 2008 |
|
RU2361572C1 |
| METHOD FOR TREATING HUMAN TUBERCULOSIS | 2002 |
|
RU2238091C2 |
| METHOD FOR PREPARING LIPOSOMAL FORM OF BIOLOGICALLY ACTIVE SUBSTANCE | 2011 |
|
RU2477632C1 |
| LIPOSOMAL ANTIVIRAL DRUG FOR ORAL USING | 1996 |
|
RU2123328C1 |
| PHOSPHOLIPID SUSPENSION CONTAINING DIHYDROQUERCETIN AND METHOD FOR PRODUCING | 2007 |
|
RU2369383C2 |
